Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: Evidence from two parallel in vitro mouse models

@article{Yorgason2010AcetaminophenOA,
  title={Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: Evidence from two parallel in vitro mouse models},
  author={Joshua G. Yorgason and Gilda M. Kalinec and William M. Luxford and Frank M. Warren and Federico Kalinec},
  journal={Otolaryngology–Head and Neck Surgery},
  year={2010},
  volume={142},
  pages={814 - 819.e2}
}

Figures from this paper

Title Acetaminophen and NAPQI are toxic to auditory cells via oxidative and endoplasmic reticulum stress-dependent pathways Permalink

Cellular, genomic, and proteomic experiments reveal that cytotoxicity by APAP and NAPQI involves two different pathways in Immortomouse -derived HEI-OC1 cells, implicating ROS overproduction, alterations in ER morphology, redistribution of intra-cisternal chaperones, activation of the eIF2a-CHOP pathway, as well as changes in ER stress and protein folding response markers.

Ototoxicity: Old and New Foes

Hearing loss linked to immunosuppressive drugs was documented in patients undergoing organ transplantation and making the patients aware of adverse drug reactions and offering them audiological monitoring and intervention should be considered by respective therapists.

In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem

This review will discuss in vitro and in vivo models of ototoxicity highlighting recently published otot toxicity research and the strengths and limitations of different ototoxic models and what molecular insights have been gained from their application.

Hearing, reactive metabolite formation, and oxidative stress in cochleae after a single acute overdose of acetaminophen: an in vivo study

There was evidence of oxidative stress which may support a role for oxidative stress in hearing loss due to chronic APAP abuse and explore possible mechanisms of APAP ototoxicity.

Ototoxicity: Old and New Foes Ototoxicity: Old and New Foes

Hearing loss linked to immunosuppres - sive drugs was documented in patients undergoing organ transplantation and making the patients aware of adverse drug reactions and offering them audiological monitoring and intervention should be considered by respective therapists.

Evaluation of the Ototoxicity Potential of Once-Daily, Single-Entity Hydrocodone in Patients with Chronic Pain: Results of Two Phase-3 Clinical Studies.

No ototoxic signal was observed for single-entity hydrocodone tablets at the dosages and treatment durations investigated and no notable differences were observed between patients receiving HYD and placebo or between different HYD doses.

Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

This review provides a narrative derived from relevant papers describing factors contributing to (or increasing the risk of) aminoglycoside and cisplatin-induced ototoxicity and highlights several interventional strategies that are currently in development, as well as the diverse challenges that still need to be overcome to prevent drug-induced hearing loss.

Impact of Nonaspirin Nonsteroidal Anti-inflammatory Agents and Acetaminophen on Sensorineural Hearing Loss

A systematic review evaluating the association between sensorineural hearing loss and nonsteroidal anti-inflammatory drugs and acetaminophen found mixed results.

Extrahepatic toxicity of acetaminophen: critical evaluation of the evidence and proposed mechanisms

The goal is to determine the strength of claims regarding extrahepatic toxicity of APAP and to identify areas of need for future research, and to view claims of developmental effects of antenatal APAP exposure with a critical eye.

References

SHOWING 1-10 OF 19 REFERENCES

A Cochlear Cell Line as an in vitro System for Drug Ototoxicity Screening

A conditionally immortalized organ of Corti-derived epithelial cell line is reported, which shows evidence of activation of apoptosis when exposed to known ototoxic drugs.

Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen‐induced lethality in mice: An explanation for high acetaminophen dosage in humans without hepatic injury

The data demonstrate an uncoupling of the traditional association between covalent binding and toxicity, and suggest that the assessment of toxicity following repeated or chronic APAP exposure must consider altered drug interactions and parameters besides those historically used to assess acute APAP overdose.

Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss.

In vivo and in vitro, the effectiveness of a strategy for preventing drug-induced hearing loss using l-carnitine (LCAR), a safe micronutrient that plays a key role in energy metabolism and detoxification, is demonstrated.

Hydrocodone use and sensorineural hearing loss.

The chronic use of hydrocodone can be associated with progressive sensorineural hearing loss and genetic polymorphisms of drug metabolizing enzymes as well as associated comorbidities such as hepatitis C infection may be significant in the development of hydocodone ototoxicity.

Profound hearing loss associated with hydrocodone/acetaminophen abuse.

Serum acetaminophen concentrations after acute overdose are not altered by opioid co-ingestion.

Early serum acetaminophen concentrations can be used to determine the extent of drug exposure, irrespective of whether an opioid has been co-ingested, despite the fact that limited data suggest opioidCo-ingestion might alteracetaminophen pharmacokinetics.

Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response

Instead of using weak opioids, small doses and controlled release formulations of strong opioids might be the future way to in analgesic therapy despite the fear of addiction and bureaucratic efforts involved with these compounds.

The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.

The data presented in this study show that only CYP2D6 humanized mice but not wild-type mice display significant DEB 4-hydroxylase activity and that HNF4alpha regulates CYP1D6 activity in vivo.

Deafness associated with acetaminophen and codeine abuse.

  • B. BlakleyH. Schilling
  • Medicine
    Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
  • 2008
Ototoxicity associated with narcotic-acetaminophen combinations is not widely recognized. This can be the cause of severe-to-profound hearing loss that may be overlooked. Otolaryngologists who